Sodium polyanethole sulfonate as an inhibitor of activation of complement function in blood culture systems

Journal of Clinical Microbiology

Volumn 48, Issue 3, 2010, Pages 908-914

  Palarasah, Yaseelan ^a   Skjoedt, Mikkel Ole ^a,b   Vitved, Lars ^a   Andersen, Thomas Emil ^c   Skjoedt, Karsten ^a   Koch, Claus ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Rigshospitalet   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C9; MAGNESIUM ION; POLYANETHOLESULFONIC ACID; PROPERDIN;

ARTICLE; BACTERIAL GROWTH; BLOOD CULTURE; BLOOD GROUP; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT FIXATION TEST; COMPLEMENT INHIBITION; COMPLEMENT LECTIN PATHWAY; CULTURE MEDIUM; GROWTH INHIBITION; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

BACTERIA; BACTERIOLOGICAL TECHNIQUES; BLOOD; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CULTURE MEDIA; HUMANS; IMMUNOLOGIC FACTORS; POLYANETHOLESULFONATE;

EID: 77749255879     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01985-09     Document Type: Article

References (20)

1. Baatrup, G., H. Jonsson, A. Sjoholm, G. Sturfelt, and S. E. Svehag. 1988. Complement fixation by solid phase immune complexes; reduced capacity in SLE sera. J. Clin. Lab. Immunol. 26:73-79.
2. Belding, M. E., and S. J. Klebanoff. 1972. Effect of sodium polyanethole sulfonate on antimicrobial systems in blood. Appl. Microbiol. 24:691-698.
3. Eng, J. 1975. Effect of sodium polyanethol sulfonate in blood cultures. J. Clin. Microbiol. 1:119-123.
4. Kindness, G., F. B. Williamson, and W. F. Long. 1979. Effect of polyanethole-sulfonic acid and xylan sulfate on antithrombin III activity. Biochem. Biophys. Res. Commun. 88:1062-1068.
5. Koch, A., M. Melbye, P. Sorensen, P. Homoe, H. O. Madsen, K. Molbak, C. H. Hansen, L. H. Andersen, G. W. Hahn, and P. Garred. 2001. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 285:1316-1321.
6. Loos, M., and D. Bitter-Suermann. 1976. Mode of interaction of different polyanions with the first (C1,C1) the second (C2) and the fourth (C4) component of complement. IV. Activation of C1 in serum by polyanions. Immunology 31:931-934.
7. Murakami, Y., I. H., E. Kitano, H. Kitamura, and Y. Ikada. 2001. Interaction of poly(2-acrylamido 2-methylpropane sulfonate)-grafted polystyrene beads with cationic complement proteins. J. Biomater. Sci. Polym. 12:451-465.
8. Petersen, S. V., S. Thiel, L. Jensen, R. Steffensen, and J. C. Jensenius. 2001. An assay for the mannan-binding lectin pathway of complement activation. J. Immunol. Methods 257:107-116.
9. Roos, A., P. Garred, M. E. Wildenberg, N. J. Lynch, J. R. Munoz, T. C. Zuiverloon, L. H. Bouwman, N. Schlagwein, F. C. Fallaux van den Houten, M. C. Faber-Krol, H. O. Madsen, W. J. Schwaeble, M. Matsushita, T. Fujita, and M. R. Daha. 2004. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur. J. Immunol. 34:2589-2598.
10. Roos, A., B. L. H., Munoz, J., Zuiverloon, T., Faber-Krol, M. C., F. C. Fllaux-van den Houten, N. Klar-Mohamad, C. E. Hack, M. G. Tilanus, and M. R. Daha. 2003. Functional characterization of the lectin pathway of complement in human serum. Mol. Immunol. 39:655-688.
11. Rotter, M. 1977. Microbiological diagnosis of septicemia. Infection 5:55-59.
12. Roy, S., K. Knox, S. Segal, D. Griffiths, C. E. Moore, K. I. Welsh, A. Smarason, N. P. Day, W. L. McPheat, D. W. Crook, and A. V. Hill. 2002. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 359:1569-1573.
13. Seelen, M. A., R. A., J. Wieslander, T. E. Mollnes, A. G. Sjöholm, R. Wurzner, M. Loos, F. Tedesco, R. B. Sim, P. Garred, E. Alexopoulos, M. W. Turner, and M. R. Daha. 2005. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. Immunol. Methods 296:187-198.
14. Sjoholm, A. G., G. Jonsson, J. H. Braconier, G. Sturfelt, and L. Truedsson. 2006. Complement deficiency and disease: an update. Mol. Immunol. 43:78-85.
15. Skjødt, M. O., J. Brandt, and L. Vitved. 2007. C3c as a fluid phase marker for inflammation: generation and characterization of monoclonal antibodies reacting against neoepitopes on split products of C3. Mol. Immunol. 44:3917.
16. Thiel, S., T. Vorup-Jensen, C. M. Stover, W. Schwaeble, S. B. Laursen, K. Poulsen, A. C. Willis, P. Eggleton, S. Hansen, U. Holmskov, K. B. Reid, and J. C. Jensenius. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386:506-510.
17. Walport, M. J. 2001. Complement: part I. N. Engl. J. Med. 344:1058-1066.
18. Walport, M. J. 2001. Complement: part II. N. Engl. J. Med. 344:1140-1144.
19. Wilkins, T. D., and S. E. West. 1976. Medium-dependent inhibition of Peptostreptococcus anaerobius by sodium polyanetholsulfonate in blood culture media. J. Clin. Microbiol. 3:393-396.
20. Zimmermann-Nielsen, E., L. H. Iversen, S. E. Svehag, O. Thorlacius-Ussing, and G. Baatrup. 2002. Activation capacity of the alternative and classic complement pathways in patients operated on for colorectal cancer. Dis. Colon Rectum 45:544-553.